Market Overview:
Micro-RNA sequencing and assay market is expected to grow at a CAGR of XX% from 2018 to 2030. The growth in the micro-RNA sequencing and assay market can be attributed to the increasing demand for personalized medicine, technological advancements in micro-RNA sequencing and assay platforms, and rising funding for research on microRNAs. However, the high cost of equipment and lack of skilled professionals are restraining the growth of this market. Sequencing by synthesis is expected to account for the largest share of the global micro-RNA sequencing and assay market in 2018. This segment is projected to grow at a CAGR of XX% from 2018 to 2030. Sequencing by nanopore technology is expected to be the fastest growing segment during this period.
Product Definition:
Micro-RNA sequencing is the process of determining the sequence of microRNAs. This information can be used to study the role of microRNAs in biology and disease. Micro-RNA assays are used to measure the levels of microRNAs in a sample. This information can be used to study the role of microRNAs in biology and disease.
Global Micro-RNA Sequencing and Assay Market Size Growth Rate : 2016 VS 2021 VS 2027:
Global microRNA sequencing and assay market was valued at USD 8.6 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 14.4% from 2021 to 2027.
Sequencing by Synthesis:
Sequencing by Synthesis (SBS) is a method used for the generation of long reads from short oligonucleotides. It allows the synthesis of longer oligonucleotides with more uniformity and accuracy than other methods such as PCR or cloning. The technology has been applied to both RNA and DNA sequencing, resulting in increased sensitivity, specificity, and capacity.
Application Insights:
The research institutes segment dominated the global market in 2016. This is attributed to the rising number of research initiatives undertaken by public and private institutions for developing microRNA sequencing as a routine procedure in diagnostic laboratories. For instance, as part of an initiative by the College of Medicine, University Of California (UC), Irvine, a study was undertaken to develop an efficient method for identifying different types of cancer cells based on their expression levels for miRNAs.
The application segment includes diagnostics and therapeutics applications. The presence of several companies involved in drug discovery & development activities coupled with ongoing clinical trials drives this segment forward.
Regional Analysis:
North America dominated the global market in 2018 owing to the presence of a substantial number of CROs that are involved in clinical trials. The region is expected to maintain its dominance over the forecast period due to ongoing and upcoming clinical trials, which require micro-RNA testing services. Asia Pacific is anticipated to grow at a lucrative rate during the forecast period owing to increasing investments by pharmaceutical companies for drug discovery and development activities. In addition, growing awareness about early diagnosis of diseases coupled with government initiatives such as “One Health†concept are some factors contributing toward regional growth.
The European market consists mainly of Germany followed by U.K.
Growth Factors:
- Increasing demand for personalized medicine
- Rising prevalence of cancer and other diseases
- Technological advancements in sequencing and assay platforms
- Growing investments in life sciences research
- Expansion of micro-RNA sequencing and assay services into new markets
Scope Of The Report
Report Attributes
Report Details
Report Title
Micro-RNA Sequencing and Assay Market Research Report
By Type
Global Micro-RNA Sequencing and Assay Market Size Growth Rate : 2016 VS 2021 VS 2027, Sequencing by Synthesis, Sequencing by Nanopore, Ion Semiconductor Sequencing
By Application
Global Micro-RNA Sequencing and Assay Market Share : 2016 VS 2021 VS 2027, Research Institute, Academia, CRO
By Companies
Illumina, Thermo Fisher Scientific, QIAGEN, Takara Bio, NEB
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
199
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Micro-RNA Sequencing and Assay Market Report Segments:
The global Micro-RNA Sequencing and Assay market is segmented on the basis of:
Types
Global Micro-RNA Sequencing and Assay Market Size Growth Rate : 2016 VS 2021 VS 2027, Sequencing by Synthesis, Sequencing by Nanopore, Ion Semiconductor Sequencing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Global Micro-RNA Sequencing and Assay Market Share : 2016 VS 2021 VS 2027, Research Institute, Academia, CRO
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Illumina
- Thermo Fisher Scientific
- QIAGEN
- Takara Bio
- NEB
Highlights of The Micro-RNA Sequencing and Assay Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Global Micro-RNA Sequencing and Assay Market Size Growth Rate : 2016 VS 2021 VS 2027
- Sequencing by Synthesis
- Sequencing by Nanopore
- Ion Semiconductor Sequencing
- By Application:
- Global Micro-RNA Sequencing and Assay Market Share : 2016 VS 2021 VS 2027
- Research Institute
- Academia
- CRO
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Micro-RNA Sequencing and Assay Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Micro-RNA sequencing and assay is a technique used to identify and quantify microRNAs in a sample. MicroRNAs are small, noncoding RNAs that play important roles in gene expression. By identifying and quantifying microRNAs in a sample, researchers can better understand the role these molecules play in cellular processes.
Some of the key players operating in the micro-rna sequencing and assay market are Illumina, Thermo Fisher Scientific, QIAGEN, Takara Bio, NEB.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Micro-RNA Sequencing and Assay Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Micro-RNA Sequencing and Assay Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Micro-RNA Sequencing and Assay Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Micro-RNA Sequencing and Assay Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Micro-RNA Sequencing and Assay Market Size & Forecast, 2018-2028
4.5.1 Micro-RNA Sequencing and Assay Market Size and Y-o-Y Growth
4.5.2 Micro-RNA Sequencing and Assay Market Absolute $ Opportunity
Chapter 5 Global Micro-RNA Sequencing and Assay Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Micro-RNA Sequencing and Assay Market Size Forecast by Type
5.2.1 Global Micro-RNA Sequencing and Assay Market Size Growth Rate : 2016 VS 2021 VS 2027
5.2.2 Sequencing by Synthesis
5.2.3 Sequencing by Nanopore
5.2.4 Ion Semiconductor Sequencing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Micro-RNA Sequencing and Assay Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Micro-RNA Sequencing and Assay Market Size Forecast by Applications
6.2.1 Global Micro-RNA Sequencing and Assay Market Share : 2016 VS 2021 VS 2027
6.2.2 Research Institute
6.2.3 Academia
6.2.4 CRO
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Micro-RNA Sequencing and Assay Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Micro-RNA Sequencing and Assay Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Micro-RNA Sequencing and Assay Analysis and Forecast
9.1 Introduction
9.2 North America Micro-RNA Sequencing and Assay Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Micro-RNA Sequencing and Assay Market Size Forecast by Type
9.6.1 Global Micro-RNA Sequencing and Assay Market Size Growth Rate : 2016 VS 2021 VS 2027
9.6.2 Sequencing by Synthesis
9.6.3 Sequencing by Nanopore
9.6.4 Ion Semiconductor Sequencing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Micro-RNA Sequencing and Assay Market Size Forecast by Applications
9.10.1 Global Micro-RNA Sequencing and Assay Market Share : 2016 VS 2021 VS 2027
9.10.2 Research Institute
9.10.3 Academia
9.10.4 CRO
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Micro-RNA Sequencing and Assay Analysis and Forecast
10.1 Introduction
10.2 Europe Micro-RNA Sequencing and Assay Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Micro-RNA Sequencing and Assay Market Size Forecast by Type
10.6.1 Global Micro-RNA Sequencing and Assay Market Size Growth Rate : 2016 VS 2021 VS 2027
10.6.2 Sequencing by Synthesis
10.6.3 Sequencing by Nanopore
10.6.4 Ion Semiconductor Sequencing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Micro-RNA Sequencing and Assay Market Size Forecast by Applications
10.10.1 Global Micro-RNA Sequencing and Assay Market Share : 2016 VS 2021 VS 2027
10.10.2 Research Institute
10.10.3 Academia
10.10.4 CRO
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Micro-RNA Sequencing and Assay Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Micro-RNA Sequencing and Assay Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Micro-RNA Sequencing and Assay Market Size Forecast by Type
11.6.1 Global Micro-RNA Sequencing and Assay Market Size Growth Rate : 2016 VS 2021 VS 2027
11.6.2 Sequencing by Synthesis
11.6.3 Sequencing by Nanopore
11.6.4 Ion Semiconductor Sequencing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Micro-RNA Sequencing and Assay Market Size Forecast by Applications
11.10.1 Global Micro-RNA Sequencing and Assay Market Share : 2016 VS 2021 VS 2027
11.10.2 Research Institute
11.10.3 Academia
11.10.4 CRO
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Micro-RNA Sequencing and Assay Analysis and Forecast
12.1 Introduction
12.2 Latin America Micro-RNA Sequencing and Assay Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Micro-RNA Sequencing and Assay Market Size Forecast by Type
12.6.1 Global Micro-RNA Sequencing and Assay Market Size Growth Rate : 2016 VS 2021 VS 2027
12.6.2 Sequencing by Synthesis
12.6.3 Sequencing by Nanopore
12.6.4 Ion Semiconductor Sequencing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Micro-RNA Sequencing and Assay Market Size Forecast by Applications
12.10.1 Global Micro-RNA Sequencing and Assay Market Share : 2016 VS 2021 VS 2027
12.10.2 Research Institute
12.10.3 Academia
12.10.4 CRO
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Micro-RNA Sequencing and Assay Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Micro-RNA Sequencing and Assay Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Micro-RNA Sequencing and Assay Market Size Forecast by Type
13.6.1 Global Micro-RNA Sequencing and Assay Market Size Growth Rate : 2016 VS 2021 VS 2027
13.6.2 Sequencing by Synthesis
13.6.3 Sequencing by Nanopore
13.6.4 Ion Semiconductor Sequencing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Micro-RNA Sequencing and Assay Market Size Forecast by Applications
13.10.1 Global Micro-RNA Sequencing and Assay Market Share : 2016 VS 2021 VS 2027
13.10.2 Research Institute
13.10.3 Academia
13.10.4 CRO
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Micro-RNA Sequencing and Assay Market: Competitive Dashboard
14.2 Global Micro-RNA Sequencing and Assay Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Illumina
14.3.2 Thermo Fisher Scientific
14.3.3 QIAGEN
14.3.4 Takara Bio
14.3.5 NEB
